THE ROLE OF CLINICAL FEATURES IN THE DIAGNOSIS OF ACUTE BRONCHIOLITIS IN CHILDREN
Keywords:
clinic, diagnosis, treatment, early age, RCV bronchiolitis, childrenAbstract
Objective: to identify diagnostic features of the clinical course and therapy of RSV-bronchiolitis in young children.
42 children under the age of 2 years with acute RSV bronchiolitis with various degrees of bronchial obstruction were examined, hospitalized in the emergency pediatrics department of the Samarkand branch of the Republican Scientific Center for Emergency Medical Care. Patients underwent a general clinical examination: complete blood and urine analysis, determination of C-reactive protein, blood gases, oxygen saturation (SpO2), chest X-ray as indicated.
RSV antigen was determined by PCR in nasopharyngeal washes. To assess the severity of bronchiolitis in children and determine hospitalization parameters, the ESBA bronchiolitis severity scale (Ramos Fernandez et all, 2013) was used, based on clinical signs, general condition, respiratory rate per minute, cardiac contraction, crepitation, presence of wheezing. RSV-bronchiolitis in children is severe with the development of respiratory failure and requires treatment in intensive care. All observed children had respiratory insufficiency (RI), indicating a severe course of the disease. In every third child, the onset of the disease was characterized by the registration of apnea. RSV-bronchiolitis in children is severe with the development of respiratory failure and requires treatment in intensive care. All observed children had respiratory insufficiency (RI), indicating a severe course of the disease. In every third child, the onset of the disease was characterized by the registration of apnea. RSV-bronchiolitis in children is severe with the development of respiratory failure and requires treatment in intensive care. Evaluation of the therapy of patients with PCB infection showed that today the problem of polypragmasia in the treatment of acute respiratory diseases in children is relevant. Observations have shown the presence of cases of unjustified antibiotic and hormone therapy.
References
Bobomuratov, T. A., Yusupova, U. U., Sharipova, O. A., & Bakhronov, S. S. (2020). The influence of ecological enviroment on the homeostatic system and the level of interleukins at acute brochitis in early age children. Central Asian Journal of Medicine, 2020(1), 84-91
Brèver А, Tomat АМ, Seghaye MC. (2019). Update оп the management of bronchiolitis. Rev Med Liege, 4(4), 175-178
Paediatric Respiratory Medicine. ERS. Handbook. 1st Edition Editors E. Eber, F. Midulla. 2013. 719 p.
American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK editor(s). Red Book: 2012 Report of the Coшmittee оп Infectious Diseases. 29th Edition. Elk Grove Village: Churchill Livingstone, 2012:609-18
Brooks C.G., Harrison W.N., Ralston S.L. Association Between Hypertonic Saline and Hospital Length of Stay in Acute Viral Bronchiolitis: A Reanalysis of 2 Meta-analyses. JAMA Pediatr. 2016; 170(6):577—84.
Santini F. Human respiratory syncytial virus and Th1 chemokines. Clin. Ter. 2015; 166(3): 203—8
Smith D.K., Seales S., Budzik C. Respiratory Syncytial Virus Bronchiolitis in Children. Am. Fam. Physician. 2017; 95(2): 94—9.
Nenna R., Cutrera R., Frassanito A., Alessandroni C., Nicolai A., Cangiano G. et al. Modifiable risk factors associated with bronchiolitis. Ther. Adv. Respir. Dis. 2017; 11(10): 393—401.
Fernandes R.M., Andrade M.G., Constant C., Malveiro D., Magalhães M., Abreu D. et al. Acute viral bronchiolitis: Physician perspectives on definition and clinically important outcomes. Pediatr. Pulmonol. 2016; 51(7): 724—32.
Chen Y.J., Lee W.L., Wang C.M., Chou H.H. Nebulized hypertonic saline treatment reduces both rate and duration of hospitalization for acute bronchiolitis in infants: an updated meta-analysis. Pediatr.Neonatol. 2014; 55(6): 431—8.
Caballero M.T., Polack F.P., Stein R.T. Viral bronchiolitis in young infants: new perspectives for management and treatment. J.Pediatr. (Rio J.). 2017 pii: S0021-7557(17)30658-7. doi: 10.1016/j. jped.2017.07.003.
Tal А., Bavilski С., Yohai D. et a1. (1983). Dexamethason and salbutamol in the treatment of acute wheezing in infants. Pediatйcs; 71 (1), 13-18.
Rivas-Juesas C, et al. A comparison of two clinical scores for bronchioli-tis. A multicentre and prospective study conducted in hospitalised infants. Allergol Immunopathol (Madr). 2017.
Gore1ick М.Н., Singh В.Ѕ., Shabalov N.P. (2006). The state of emergency in the pathology of the respiratory system. Secrets emergency pediatrics: translation from English. Moscow: MED press-inform, 277—291.
Purcell К, Fergie Ј. (2007). Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections Pediatr Infect Dis J, 26(4),311-315.
Shakhanova Sh.Sh., Abdurakhmonov J.A., Rakhimov, N.M.. (2023). Targeted therapy in the palliative treatment of platinum-resistant recurrent ovarian cancer complicated by ascites. The American Journal of Medical Sciences and Pharmaceutical Research, 5(08), 77–81.
Hall CB.Respiratory syncytial virus: What we know now. (2014). Contemp. Pediatr, (10), 92-110.
O'Connell К., Boo T.W., Keady D., Niriain U., O'Donovan D., Commane М. et a1. (2011). Use of palivizumab and infection control measures to control ап outbreak of respiratory syncytial virus in а neonatal intensive care unit confirmed by real-time polymerase chain reaction. Ј. Hosp. Infect., (77), 338-342.
Статья поступила в редакцию 28.10.2023; одобрена после рецензирования 22.12.2023; принята к публикации 25.12.2023.
The article was submitted 28.10.2023; approved after reviewing 22.12.2023; accepted for publication 25.12.2023
Информация об авторах:
Азимова Камола Талатовна-Ассистент, кафедра педиатрии №3 и медицинской генетики, Самаркандский государственный медицинский университет, Самарканд, Узбекистан. Е-mail: kamolaazi@gmail.com, ORCID ID: https://orcid.org/0009-0005-9313-2487
Гарифулина Лиля Маратовна- к.м.н., доцент, кафедра педиатрии лечебного факультета, Самаркандский государственный медицинский университет, Самарканд. Узбекистан. Е-mail:ms.garifulina77@mai1.ru, ORCID ID: http.://orcid.org/0000-0003-2163-0047
Источники финансирования: Работа не имела специального финансирования.
Конфликт интересов: Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Вклад авторов:
Гарифулина Л.М. — идеологическая концепция работы, написание текста; редактирование статьи;
Азимова К.Т. — сбор и анализ источников литературы, написание текста.
Information about the authors:
AZIMOVA Kamola Talatovna-Assistant, Department of Pediatrics No. 3 and Medical Genetics, Samarkand State Medical University, Samarkand, Uzbekistan. E-mail: kamolaazi@gmail.com, ORCID ID: https://orcid.org/0009-0005-9313-2487
Garifulina Lilya Maratovna - Candidate of Medical Sciences, Associate Professor, Department of Pediatrics, Faculty of Medicine, Samarkand State Medical University, Samarkand. Uzbekistan. Е-mail:ms.garifulina77@mai1.ru, ORCID ID: http.://orcid.org/0000-0003-2163-0047
Sources of funding: The work did not have special funding.
Conflict of interest: The authors declare that there are no obvious or potential conflicts of interest related to the publication of this article.
Authors' contributions:
Garifulina L.M. — ideological concept of the work, writing the text; article editing;
Azimova K.T. — collection and analysis of literature sources, writing text.
